FastMarket.news

TSMC Faces US Probe Over Huawei Chip Manufacturing

Published 16 days agoTSM
TSMC Faces US Probe Over Huawei Chip Manufacturing

The US Commerce Department is currently investigating Taiwan Semiconductor Manufacturing Company (TSMC) over potential violations of export controls concerning its chip production for Huawei Technologies. The probe is centered on whether TSMC has been involved in manufacturing smartphone chips for Huawei's Mate 60 series or AI server chips through intermediaries, which could contravene US sanctions against Huawei.


According to reports, if TSMC is found guilty of breaching these export controls, it could be subject to significant penalties, including fines exceeding $1 billion or temporary restrictions on accessing US technology. As TSMC heavily relies on US technology for its advanced chip production, such penalties could pose a substantial threat to its operations and strategic plans.


Despite the ongoing investigation, TSMC remains focused on complying with existing export controls. The company is still slated to receive substantial subsidies from the US for its Arizona fabrication plant, demonstrating continued US support. Nevertheless, the probe underscores the broader challenges faced by the semiconductor industry amidst geopolitical tensions and evolving US export regulations, as noted by publications like Insider Monkey.

Share this article

Recent Articles

Gilead Sciences Boosts Dividend for Tenth Consecutive Year

Gilead Sciences Boosts Dividend for Tenth Consecutive Year

16 minutes agoGILD

Gilead Sciences has announced a quarterly dividend of $0.79 per share for the second quarter of 2025. The dividend will be payable on June 25, 2025, to shareholders recorded by June 11, 2025. This move marks an increase of 2.6% from previous dividends, continuing the company's decade-long trend of annual dividend hikes. The decision to raise the dividend underscores Gilead's confidence in its robust financial standing. Recently, the company reported strong earnings that exceeded analyst predictions, contributing to its reputation for financial stability. Such consistent performance has allowed Gilead to enhance shareholder returns through dividends. In a statement regarding the dividend increase, Gilead Sciences highlighted its steadfast commitment to returning value to its shareholders. The board of directors maintains the flexibility to assess and declare future dividends, pointing to Gilead's strategic focus on leveraging its solid financial position to benefit its investors, as reported by Insider Monkey.

NetEase Restructures Amidst Leadership and Studio Changes

NetEase Restructures Amidst Leadership and Studio Changes

46 minutes agoNTES

NetEase is undergoing significant restructuring within its global operations, involving leadership changes and studio closures. The company has seen notable shifts, including the departure of Xiaojun Hui, president of NetEase Games, as part of a broader overhaul that includes hiring recent finance graduates for key roles. Meanwhile, the company has denied rumors of wide-scale layoffs despite these changes. The restructuring comes alongside NetEase's decision to close or pause operations at several overseas studios, such as Ouka in Japan, Worlds Untold in Canada, and Jar of Sparks in the U.S., with fewer than 60 employees affected by these closures. Insider Monkey reports that while aggressive expansion marked previous years, the current strategy marks a step back with a focus on core operations, though key studios like BulletFarm remain operational. These moves reflect NetEase's strategic pivot after years of global expansion, as they re-evaluate their international strategies amid industry concerns about talent churn and studio instability. According to Insider Monkey, the company’s adjustments illustrate the challenges of maintaining a wide-reaching operational footprint in a dynamic industry landscape.

Lithia & Driveway Boosts Dividend Amid Strong Q1 Results

Lithia & Driveway Boosts Dividend Amid Strong Q1 Results

1 hours agoLAD

Lithia & Driveway (NYSE: LAD) has announced an increase in its quarterly dividend to $0.55 per share for the first quarter of 2025, marking a rise of 3.8% to 4% from its previous dividend payment. The dividend will be distributed to shareholders on record as of May 9, 2025, with a payment date set for May 23, 2025. This move underscores the company's robust financial health and commitment to shareholder returns. The dividend hike follows a strong financial performance in the first quarter, with Lithia reporting a 7% year-over-year rise in revenue, reaching $9.2 billion. This growth was driven by a 9.1% increase in new vehicle sales and improved margins in aftersales operations. Net income for the quarter increased by 28% to $211 million, and diluted earnings per share surged 35% to $7.94, demonstrating the company's operational efficiency and their scale advantages. Lithia & Driveway maintains a low payout ratio of approximately 6.53% relative to earnings, suggesting potential for further dividend growth. Besides increasing dividends, the company has been actively repurchasing shares, buying back around 403,000 shares in Q1 2025 with $669.2 million still available under the current share repurchase authorization. According to Insider Monkey, Lithia is recognized as the world's largest automotive retailer, offering a comprehensive range of products and services spanning the vehicle ownership lifecycle through various channels including e-commerce.

Cyclacel Pharmaceuticals Declares Preferred Stock Dividend Amid Financial Challenges

Cyclacel Pharmaceuticals Declares Preferred Stock Dividend Amid Financial Challenges

1 hours agoCYCC

Cyclacel Pharmaceuticals has declared a quarterly cash dividend of $0.15 per share for its 6% Convertible Exchangeable Preferred Stock. According to the company, the dividend is set to be paid on May 1, 2025, with stockholders of record as of April 29, 2025, eligible to receive the payment. Cyclacel Pharmaceuticals, a biopharmaceutical company listed on NASDAQ under the ticker CYCC, has a market capitalization of approximately $47 million. It trades at $0.23 per share and notably does not pay dividends to its common stockholders. However, despite the dividend announcement, the company's financial health raises concerns as its stock has plummeted nearly 83% over the past six months. Additionally, it has a current ratio of 0.59, indicating liabilities exceed current liquid assets, as reported by Insider Monkey. The company has not committed to continuing the dividend payments into future quarters. This decision is dependent on Cyclacel's financial state and other market factors, and no assurance can be given regarding future distributions. The company's recent challenges are evident, influencing its strategic financial planning moving forward.